Review summarizes mitochondrial dysfunction role in diabetic wounds and potential therapeutic strategies

This narrative review article summarizes existing literature on the role of mitochondrial dysfunction in diabetic wound healing impairment. The authors describe how mitochondrial dysfunction, through mechanisms including excessive reactive oxygen species production, mitochondrial DNA leakage, and aberrant inflammasome activation, may exacerbate inflammation and impede healing in diabetic wounds. The review outlines various potential mitochondria-targeting therapeutic strategies discussed in the literature.

No specific study population, sample size, intervention, comparator, or outcomes are reported, as this is a summary of existing literature rather than a primary study. The article does not present new experimental data, effect sizes, or statistical certainty regarding any therapeutic approach.

Safety and tolerability information for any specific intervention is not reported. The authors note that therapeutic strategies are discussed as potential or theoretical approaches, with no efficacy or safety data from human studies presented. The review's limitations include its narrative nature and lack of primary data.

For clinical practice, this review provides a conceptual framework for understanding mitochondrial involvement in diabetic wound pathology. However, clinicians should recognize that no specific therapeutic recommendations can be made based on this summary alone, as it lacks clinical trial evidence, comparative effectiveness data, and safety information for any intervention targeting mitochondrial function in diabetic wounds.